Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Rabourn Amy Zaremba

Head Of Fin. Quality Assurance at Opus Genetics, Inc. (IRD)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $23K

Reported trades

Filed Stock Type Shares Price Value Since
Apr 27SEC IRDOpus Genetics, Inc. Sell 1,641188,671 held (−1%) $5.20 $9K -26.2%
Mar 18SEC IRDOpus Genetics, Inc. Sell 2,816190,312 held (−1%) $5.25 $15K -26.9%